Pre-Market Movers: CG Oncology Jumps on Phase 3 Win, Telus on Québecor Approach
CG Oncology rose 32.39% and Telus 22.04% in Monday's pre-market, while Global Mofy AI more than quintupled on a thin float. Summit Therapeutics announced an FDA complete response letter on Sunday.


